Overview
Arimidex is classified as a PCT (post-cycle therapy) and ancillary compound. Non-steroidal, reversible (competitive) aromatase inhibitor.
With a half-life of ~2 days (48 hours), Arimidex supports less frequent dosing schedules. Taken orally, it has a bioavailability of approximately 95% via its primary route.
Half-life approximately 48 hours. Aromatase activity recovers upon discontinuation. One-compartment model.
Mechanism of Action
Arimidex's pharmacological activity involves the following key pathways:
Aromatase Inhibition
Arimidex reduces the conversion of androgens to estrogens by inhibiting the aromatase enzyme. This directly lowers circulating estrogen levels.
Competitive Binding
Arimidex is a non-steroidal, reversible aromatase inhibitor. It competes with the natural substrate for the enzyme's active site.
Dosing Protocols
The following protocols represent commonly observed dosing patterns. These are observational summaries, not recommendations.
Dose
0.25 mg/day
Route
Oral
Frequency
Every other day
Duration
4-8 weeks
Dose
1 mg/day
Route
Oral
Frequency
Every other day
Duration
4-8 weeks
Frequently Asked Questions
What is anastrozole and how does it work?
Anastrozole (brand name Arimidex) is a third-generation non-steroidal aromatase inhibitor (AI) that works by reversibly binding to the aromatase enzyme, blocking the conversion of androgens into estrogen. It reduces circulating estradiol levels by approximately 70–80%. In the context of testosterone and anabolic steroid use, it is commonly used to manage estrogen-related effects that arise from the aromatization of exogenous testosterone.
What is the half-life of anastrozole and how long until steady state?
Anastrozole has a terminal elimination half-life of approximately 40–50 hours (roughly 2 days). Plasma concentrations approach steady-state levels at about 7 days of consistent dosing, at which point levels are approximately 3–4 times higher than after a single dose. The pharmacokinetics are linear across a wide dose range, meaning the relationship between dose and blood levels is predictable.
What are the common side effects of anastrozole in men?
The most commonly observed effects in men relate to excessive estrogen suppression: joint pain and stiffness (arthralgia), dry skin, reduced libido, fatigue, mood changes, and decreased bone mineral density over time. These effects are dose-dependent and are generally associated with estradiol being driven too low. Regular bloodwork is the standard approach for titrating dose to maintain estradiol within an appropriate range rather than suppressing it completely.
What is the typical anastrozole dosage for estrogen management?
Dosing is highly individual and depends on the degree of aromatization occurring. In TRT contexts, commonly observed starting doses range from 0.25–0.5 mg taken two to three times per week. In higher-dose testosterone or multi-compound cycles, 0.5–1 mg every other day is more frequently reported. Bloodwork-guided titration is the standard practice, as the goal is estrogen management rather than estrogen elimination.
Can anastrozole crash estrogen levels?
Yes. Anastrozole is potent enough to drive estradiol well below the normal male range (20–30 pg/mL), particularly at higher doses or in individuals who aromatize less than average. Symptoms of excessively low estrogen include severe joint pain, low libido, brain fog, dry skin, and mood disturbances. Because anastrozole is a reversible inhibitor, estrogen levels typically recover within a few days of reducing or discontinuing the dose.
How does anastrozole compare to exemestane and letrozole?
Anastrozole is a reversible, non-steroidal AI – meaning estrogen levels recover relatively quickly after discontinuation. Exemestane (Aromasin) is an irreversible “suicide” inhibitor, so the body must synthesize new aromatase enzyme to restore activity. Letrozole (Femara) is the most potent of the three, capable of suppressing estradiol by up to 98%. Anastrozole is often considered the most commonly used AI alongside TRT due to its moderate potency and predictable, reversible pharmacokinetics.